The report analyzes the key drivers, restraints, recent trends, and growth opportunities in the global market for in situ hybridization. The market shares, product portfolios, technological developments, and business strategies of the major players are discussed in detail.
Albany, NY -- (SBWIRE) -- 03/02/2017 -- The global market for in situ hybridization is projected to expand at a phenomenal rate, with the cancer diagnosis segment at the forefront. The in situ hybridization market can include application segments such as neuroscience, cancer diagnosis, immunology, cytology, microbiology, pathology, and developmental biology.
In situ hybridization is a powerful method for localizing specific nucleic acid targets in cells and tissues, thereby allowing access to the temporal and spatial information about genetic loci and structure. Human DNA and RNA can be visualized with the help of in situ hybridization in two major ways, chromogenic (CISH) and fluorescence (FISH) detection.
Request a Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=782
The report analyzes the key drivers, restraints, recent trends, and growth opportunities in the global market for in situ hybridization. The market shares, product portfolios, technological developments, and business strategies of the major players are discussed in detail. The report also sheds light on factors such as market size, supply and demand ratio, market attractiveness, and key segments of the in situ hybridization market.
Global In Situ Hybridization Market: Drivers and Restraints
Technological advancements in the field of in situ hybridization, such as development of the cytogenetic technique, is one of the key factors driving the market. The rising prevalence of cancer has necessitated clinical research, which is another major market driver. The introduction of new therapeutic agents has led to a high rate of adoption of companion diagnostics, boosting the overall market expansion. Besides these factors, the growth of the pharmaceutical and biotechnology industry has improved the prospects of the in situ hybridization market worldwide.
Request for TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=782
Florescence in situ hybridization (FISH) can be used in the detection of genetic abnormalities such as aneuploidy, characteristic gene fusion, or loss of a chromosomal region. It is also useful for research in the fields of gene mapping and identification of genetic aberrations, which are responsible for cancer. As this technique is simple yet effective, FISH will ensure the growth of the global in situ hybridization market.
On the contrary, strict regulatory policies will obstruct the growth of the in situ hybridization market. However, the emergence of molecular cytogenetics will present significant opportunities due to unmet needs in accurate disease diagnosis, rising number of chromosomal disorders, and surge in population.
Global In Situ Hybridization Market: Regional Outlook
On the basis of geography, the global market for in situ hybridization can be segmented into Europe, Asia Pacific, Latin America, North America, and the Middle East and Africa. North America holds a large share in the overall market, with Europe and Asia Pacific also exhibiting promising growth. Extensive research activities in countries such as Canada and the U.S., increased adoption of companion diagnostics, and beneficial government policies have been aiding the in situ hybridization market in North America.
Read Complete Report @ https://www.tmrresearch.com/in-situ-hybridization-market
Over the forecast period 2017-2025, Asia Pacific will undergo tremendous growth on account of growing incidence of cancer and its diagnosis, increased healthcare expenditure, and increasing health awareness among people. The presence of international companies in countries such as India and China will further provide an impetus to the market.
Companies Mentioned in the Report
The major companies operating in the market for in situ hybridization include Bio Sb, Inc., Advanced Cell Diagnostics, Inc., Merck KGaA, Abbott Laboratories, Inc., Leica Biosystems Nussloch GmbH, Danaher Corporation, and Agilent Technologies. Several companies are using business strategies such as product enhancement, collaborations, acquisitions, and partnerships with a view to increasing profit.
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todayâ€™s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clientsâ€™ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.